Updates are available Correction dated 2024-07-10
Click to view Correction: https://doi.org/10.1186/s12883-024-03743-8
-
Authors
Moes, Harmen R.
Buskens, Erik
van Laar, Teus
-
Funding
Funding for this research was provided by:
Parkinson Vereniging (2017-R04)
Universitair Medisch Centrum Groningen (GR-AGIKO 18-02)
- License Information
-
More Information
Article History
Received: 20 November 2023
Accepted: 24 May 2024
First Online: 5 June 2024
Change Date: 10 July 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12883-024-03743-8
Declarations
:
: Not applicable.
: Not applicable.
: TvL reports having received consulting fees from AbbVie, Britannia Pharm., Eurocept, and Clexio, and research grants from the Michael J. Fox Foundation, the Dutch Brain Foundation, and the University Medical Center Groningen, all unrelated to this work. HRM and EB declare no competing interests.
: HRM received the aforementioned grants for the research project “Development of a screening tool for timely referral for advanced therapy in Parkinson’s disease”. This ongoing project aims to develop and validate a clinical decision model using data from two large cohorts with prospectively collected data.
